Regardless of Preliminary skepticism, recent advancements in peptide drug discovery have rejuvenated curiosity in peptides as therapeutic brokers, with about 70 peptides now marketed and a number of other others in clinical development.Short protein and peptide therapeutics produced by genetic code expansion also have a short half-existence as a co